This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
The de-intensification from a multiple daily injection insulin regimen to once-daily iGlarLixi showed similar glucose control and greater weight loss without an increased risk for hypoglycemia.
Medscape Medical News